Cases & Deals

  • Home
  • Practices
  • Athyrium Capital invests €15 million in Medicrea via convertible bond placement

Share

Athyrium Capital invests €15 million in Medicrea via convertible bond placement

August 2016

Client(s) Athyrium Capital Management LP

Jones Day represented Athyrium Capital Management LP, as sole investor, in connection with its €15 million (US$16.7 million) investment in Medicrea International SA, a manufacturer of medical devices, through the purchase of 6.75% Senior Convertible Bonds due 2020 in a private placement.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.